Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0031099 (
periodontitis
)
12,489
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Periodontitis
is an inflammatory disease, which, when severe, can result in tooth loss, that affects the quality of life.
S100A2
was previously identified as a component of gingival crevicular fluid (GCF) via proteome analysis, but it has not been investigated whether
S100A2
plays a role in
periodontitis
. In this study, we analyzed mRNA expression of
S100A2
in gingival tissues from normal and classified periodontal disease patients and compared it to that of S100A8 and S100A9. Quantitative real time-PCR revealed that the mRNA expression levels of
S100A2
, S100A8, and S100A9 were significantly upregulated in gingival tissues with gingivitis, moderate
periodontitis
, and severe
periodontitis
compared to normal tissues. In addition,
S100A2
proteins in GCF and the conditioned media of lipopolysaccharide (LPS)-treated Jurkat cells were confirmed by ELISA.
S100A2
protein levels were significantly higher in GCF in gingivitis and moderate
periodontitis
groups than in normal groups.
S100A2
mRNA expression and protein secretion were also increased by LPS stimulation. Based on the up-regulation of
S100A2
in LPS-stimulated immune cells, gingival tissues and GCF from periodontal disease groups, we conclude that
S100A2
is a functional component in the immune response during
periodontitis
and may serve as a potential biomarker for
periodontitis
.
...
PMID:S100A2 level changes are related to human periodontitis. 2192 97